Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $288.17 Million |
|---|---|
| Enterprise Value | $219.42 Million |
| Earnings per Share | $-0.33 |
| Beta | 0.81 |
| Outstanding Shares | 93,866,642 |
| P/E Ratio | -2.81 |
|---|---|
| PEG | -14.39 |
| Price to Sales | - |
| Price to Book Ratio | 3.07 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.49 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing compounds that activate Tie2 for indications in which the Company believes that activation of Tie2 may have therapeutic potential. The Company's lead compo...